HRT Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,711
| Closed | -$333K | – | 2834 |
|
|
2023
Q3 | $333K | Sell |
32,711
-11,275
| -26% | -$115K | ﹤0.01% | 1431 |
|
|
2023
Q2 | $331K | Buy |
43,986
+13,027
| +42% | +$98K | ﹤0.01% | 1422 |
|
|
2023
Q1 | $273K | Buy |
+30,959
| New | +$273K | ﹤0.01% | 1618 |
|
|
2022
Q3 | – | Sell |
-34,427
| Closed | -$258K | – | 3320 |
|
|
2022
Q2 | $258K | Buy |
+34,427
| New | +$258K | ﹤0.01% | 2054 |
|
|
2021
Q3 | – | Sell |
-25,944
| Closed | -$256K | – | 3496 |
|
|
2021
Q2 | $256K | Sell |
25,944
-8,865
| -25% | -$87.5K | ﹤0.01% | 2152 |
|
|
2021
Q1 | $401K | Buy |
34,809
+16,122
| +86% | +$186K | ﹤0.01% | 1753 |
|
|
2020
Q4 | $180K | Buy |
+18,687
| New | +$180K | ﹤0.01% | 1445 |
|
|
2020
Q2 | – | Sell |
-16,105
| Closed | -$144K | – | 1609 |
|
|
2020
Q1 | $144K | Buy |
+16,105
| New | +$144K | 0.01% | 474 |
|
|
2019
Q4 | – | Sell |
-15,400
| Closed | -$105K | – | 1541 |
|
|
2019
Q3 | $105K | Buy |
+15,400
| New | +$105K | 0.01% | 1133 |
|
|
2019
Q2 | – | Sell |
-25,491
| Closed | -$399K | – | 882 |
|
|
2019
Q1 | $399K | Sell |
25,491
-10,002
| -28% | -$157K | 0.06% | 205 |
|
|
2018
Q4 | $547K | Buy |
+35,493
| New | +$547K | 0.08% | 190 |
|